MolNFT v1 · #103625 · protein

Crystal structure of ctx-M-14 S70G:S237A:R276A beta-lactamase in complex with cefotaxime at 1.45 ångströms resolution

4PM9 · Beta-lactamase ctx-M-14: “Crystal structure of ctx-M-14 S70G:S237A:R276A beta-lactamase in complex with cefotaxime at 1.45 ångströms…”. X-ray diffraction, 1 ligand (CE3), 1 pocket (best druggability 0.35). MolNFT v1 #103625 on…

PDB: 4PM9
Type: protein
Length: 262 residues
Chains: 1
Method: x-ray diffraction
Collection: MolNFT v1 / PDB
Contract: 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner: 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule: Beta-lactamase ctx-M-14
UniProt: G8XD06
Ligands: CE3
Pockets: 1 · best druggability 0.35

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 19% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	Beta-lactamase ctx-M-14	protein	262	42% helix, 19% strand	G8XD06

Ligands and binding sites

CE3 · (6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-ethanoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	105	0.35	0.74	26	CE3

Compared structures

4PM9 · Crystal structure of CTX-M-14 S70G:S237A:R276A beta-lactamase in complex with cefotaxime… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt G8XD06
Elsewhere: RCSB PDB 4PM9 · PDBe 4PM9 · UniProt G8XD06

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.